Condition
Peripheral Spondyloarthritis
Total Trials
3
Recruiting
0
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 3 (2)
Trial Status
Active Not Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04435288Phase 3Active Not RecruitingPrimary
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
NCT06715488Active Not Recruiting
Automated Arthritis Detection Using Artificial Intelligence on Smartphone Photographs
NCT01064856Phase 3CompletedPrimary
Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)
Showing all 3 trials